SOC Telemed (TLMD) Filings

15-12B

Securities registration termination

18 Apr 22

EFFECT

Notice of effectiveness

11 Apr 22

EFFECT

Notice of effectiveness

11 Apr 22

POS AM

Prospectus update (post-effective amendment)

6 Apr 22

POS AM

Prospectus update (post-effective amendment)

6 Apr 22

S-8 POS

Registration of securities for employees (post-effective amendment)

6 Apr 22

RW

Registration withdrawal request

6 Apr 22

25-NSE

Exchange delisting

6 Apr 22

8-K

SOC Telemed Completes Acquisition by Patient Square Capital

6 Apr 22

8-K

Submission of Matters to a Vote of Security Holders

4 Apr 22

DEFA14A

Additional proxy soliciting materials

31 Mar 22

10-K

2021 FY

Annual report

30 Mar 22

8-K

SOC Telemed Reports Fourth Quarter and Full Year 2021 Financial and Operating Results

30 Mar 22

DEFM14A

Proxy related to merger

7 Mar 22

PREM14A

Preliminary proxy related to merger

23 Feb 22

DEFA14A

Additional proxy soliciting materials

4 Feb 22

8-K

Voting and Support Agreement

4 Feb 22

DEFA14A

Additional proxy soliciting materials

3 Feb 22

DEFA14A

Additional proxy soliciting materials

3 Feb 22

DEFA14A

Additional proxy soliciting materials

3 Feb 22

DEFA14A

Additional proxy soliciting materials

3 Feb 22

8-K

SOC Telemed to be Acquired by Patient Square Capital

3 Feb 22

8-K/A

Departure of Directors or Certain Officers

29 Dec 21

8-K

Departure of Directors or Certain Officers

27 Dec 21

EFFECT

Notice of effectiveness

15 Dec 21

424B3

Prospectus supplement

10 Dec 21

424B3

Prospectus supplement

10 Dec 21

EFFECT

Notice of effectiveness

10 Dec 21

EFFECT

Notice of effectiveness

10 Dec 21

CORRESP

Correspondence with SEC

10 Dec 21

UPLOAD

Letter from SEC

10 Dec 21

POS AM

Prospectus update (post-effective amendment)

7 Dec 21

POS AM

Prospectus update (post-effective amendment)

7 Dec 21

S-3

Shelf registration

7 Dec 21

424B3

Prospectus supplement

12 Nov 21

424B3

Prospectus supplement

12 Nov 21

424B3

Prospectus supplement

3 Nov 21

424B3

Prospectus supplement

3 Nov 21

8-K

Cost Associated with Exit or Disposal Activities

3 Nov 21

SC 13D/A

WARBURG PINCUS & CO.

7 Apr 22

4

Change in insider ownership

7 Apr 22

4

Change in insider ownership

7 Apr 22

4

STEVEN J SHULMAN

7 Apr 22

4

David Mikula

7 Apr 22

4

Anne McGeorge

7 Apr 22

4

Amr Kronfol

7 Apr 22

4

Eunice Kim

7 Apr 22

4

Robert Jason Hallock

7 Apr 22

4

Joseph P Greskoviak

7 Apr 22

4

Christopher M. Gallagher

7 Apr 22

4

David R. Fletcher

7 Apr 22

4

Gyasi C. Chisley

7 Apr 22

4

THOMAS J. CARELLA

7 Apr 22

4

Barbara Peterson Byrne

7 Apr 22

4

Robert Jason Hallock

4 Apr 22

SC 13G

Beryl Capital Management LLC

24 Mar 22

SC 13G/A

INTEGRATED CORE STRATEGIES (US) LLC

14 Feb 22

SC 13G/A

Alyeska Investment Group, L.P.

14 Feb 22

SC 13G/A

BlackRock Inc.

9 Feb 22

SC 13G

BlackRock Inc.

7 Feb 22

SC 13D/A

WARBURG PINCUS & CO.

4 Feb 22

4

Christopher M. Gallagher

22 Dec 21

4

David Mikula

22 Dec 21

3

David R. Fletcher

1 Oct 21

3

David Mikula

14 Sep 21

SC 13G

INTEGRATED CORE STRATEGIES (US) LLC

15 Jun 21

4

STEVEN J SHULMAN

7 Jun 21

4

Anne McGeorge

7 Jun 21

4

Amr Kronfol

7 Jun 21

4

Joseph P Greskoviak

7 Jun 21

4

THOMAS J. CARELLA

7 Jun 21

4

Barbara Peterson Byrne

7 Jun 21

SC 13G

INTEGRATED CORE STRATEGIES (US) LLC

7 Jun 21

SC 13D/A

WARBURG PINCUS & CO.

3 Jun 21

4

Gyasi C. Chisley

6 May 21

3

Gyasi C. Chisley

6 May 21

3

Christopher M. Gallagher

7 Apr 21

SC 13D/A

WARBURG PINCUS & CO.

31 Mar 21

4

Joseph P Greskoviak

22 Mar 21